Advertisement
Home 2015 October

Monthly Archives: October 2015

When it comes to treating seniors with diabetes

Many Seniors May Be Overtreated for T2DM, Hypertension

Physicians may be concerned about malpractice claims or performance measure variables

American Society of Anesthesiologists, Oct. 24-28

ANESTHESIOLOGY 2015 The annual meeting of the American Society of Anesthesiologists was held from Oct. 24 to 28 in San Diego and attracted...
In a new study on how often medication errors occur during surgery

ASA: Peri-Op Medication Errors Far Too Common

And most of the mistakes are preventable, researchers report
Concurrent use of heroin and prescription opioids is increasing

More Prescription Opioid Addicts Are Turning to Heroin

Interviews with addicts confirm desire for cheaper, more plentiful substitute
Type 2 diabetes still substantially increases mortality risk

Despite Progress, Mortality Still Risk Up in Patients With T2DM

Risks vary per age, glycemic control, and renal complications
Lynparza (olaparib) targets mutations found in about 30 percent of men with prostate cancer

Ovarian Cancer Rx Promising for Prostate Tumors

In small study, olaparib targeted gene mutation in men who had failed other therapy
For patients with acute myocardial infarction

Part D Enrollment Doesn’t Improve Outcomes After AMI

Half of AMI patients enrolled in Part D by hospital discharge; outcomes no better than non-enrollees
For patients with rheumatoid arthritis and inflammatory bowel disease with prior nonmelanoma skin cancer (NMSC)

Some RA Treatments Up Second Nonmelanoma Skin Cancer Risk

Increased risk with methotrexate, and for anti-TNF drugs in conjunction with methotrexate
Computed tomography findings affect the diagnosis and management of suspected community-acquired pneumonia

Early CT Scan Impacts Management of Suspected CAP

CT scan modified classification in 58.6 percent of patients presenting to ER with suspected CAP
For patients with liver cirrhosis

Low-Dose Rifaximin Cuts Endotoxin Level in Cirrhosis

Similar reduction in serum endotoxin level for low-dose, high-dose rifaximin